Publications

Publications | Masters and Phd thesis

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

Publications

In Press | 2019 | ...

In Press

Bi-allelic Variants in DYNC1I2 Cause Syndromic Microcephaly with Intellectual Disability, Cerebral Malformations, and Dysmorphic Facial Features.

Ansar M., Ullah F., Paracha S.A., Adams D.J., Lai A., Pais L., Iwaszkiewicz J., Millan F., Sarwar M.T., Agha Z. et al. American journal of human genetics. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_29D795794213]

Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.

Berner F., Bomze D., Diem S., Ali O.H., Fässler M., Ring S., Niederer R., Ackermann C.J., Baumgaertner P., Pikor N. et al. JAMA oncology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_D4ABE4711190]

High-throughput screening of human tumor-antigen specific CD4 T cells, including neo-antigen reactive T cells.

Costa-Nunes C., Cachot A., Bobisse S., Arnaud M., Genolet R., Baumgaertner P., Speiser D.E., Sousa Alves P.M., Sandoval F., Adotévi O. et al. Clinical cancer research. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_99ED3D648751]

SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.

Daina A., Michielin O., Zoete V. Nucleic acids research. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_37625953AF4B]

Tumor Landscapes: β-Catenin Drives Immune Desertification.

Dangaj D., Barras D., Coukos G. Clinical cancer research. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_7529A1E77088]

Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.

Digklia A., Duran R., Homicsko K., Kandalaft L.E., Hocquelet A., Orcurto A., Coukos G., Denys A. Cardiovascular and interventional radiology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_13E5E5B29D1D]

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.

Jreige M., Letovanec I., Chaba K., Renaud S., Rusakiewicz S., Cristina V., Peters S., Krueger T., de Leval L., Kandalaft L.E. et al. European journal of nuclear medicine and molecular imaging. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_4F575C6723CE]

Meta-Analysis in Metastatic Uveal Melanoma to Determine Progression-Free and Overall Survival Benchmarks: an International Rare Cancers Initiative (IRCI) Ocular Melanoma study.

Khoja L., Atenafu E.G., Suciu S., Leyvraz S., Sato T., Marshall E., Keilholz U., Zimmer L., Patel S.P., Piperno-Neumann S. et al. Annals of oncology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_BD137DAA9150]

MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma.

Martinez-Usatorre A., Sempere L.F., Carmona S.J., Carretero-Iglesia L., Monnot G., Speiser D.E., Rufer N., Donda A., Zehn D., Jandus C. et al. Cancer immunology research. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_4CB1877985DB]

Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.

Saavedra D., Fuertes S.A., Suárez G.M., González A., Lorenzo-Luaces P., García B., Aznar E., Mazorra Z., Crombet T., Speiser D.E. et al. Experimental gerontology p. 110633. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_6E061DCF6353]

The pro- and anti-tumor role of ILC2s.

Trabanelli S., Chevalier M.F., Derré L., Jandus C. Seminars in immunology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_ECAD6DCB8107]

2019

Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice.

Cicone F., Gnesin S., Denoël T., Stora T., van der Meulen N.P., Müller C., Vermeulen C., Benešová M., Köster U., Johnston K. et al., 2019/06/11. EJNMMI research, 9 (1) p. 53. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_22C26DF26A4B]

Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation.

Lenti E., Bianchessi S., Proulx S.T., Palano M.T., Genovese L., Raccosta L., Spinelli A., Drago D., Andolfo A., Alfano M. et al., 2019/06/11. Stem cell reports, 12 (6) pp. 1260-1268. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_51D0703A660E]

Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.

Dangaj D., Bruand M., Grimm A.J., Ronet C., Barras D., Duttagupta P.A., Lanitis E., Duraiswamy J., Tanyi J.L., Benencia F. et al., 2019/06/10. Cancer cell, 35 (6) pp. 885-900.e10. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_95C8776874F3]

Re-education of macrophages as a therapeutic strategy in cancer.

Kowal J., Kornete M., Joyce J.A., 2019/06. Immunotherapy, 11 (8) pp. 677-689. Peer-reviewed.

[URN] [DOI] [Pmid] [serval:BIB_7E2B9DDA760A]

Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.

Saglietti C., La Rosa S., Sykiotis G.P., Letovanec I., Bulliard J.L., Piana S., Mermod M., Petrova T., Uccella S., Sessa F. et al., 2019/06. Endocrine pathology, 30 (2) pp. 138-145. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_564B70BCE78F]

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen M.O., Heath M.D., Cabral-Miranda G., Lipp C., Zeltins A., Sande M., Stein J.V., Riether C., Roesti E., Zha L. et al., 2019/05/23..

[DOI] [WoS] [Pmid] [serval:BIB_F6CF25B028EC]

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients.

Broggi MAS, Maillat L., Clement C.C., Bordry N., Corthésy P., Auger A., Matter M., Hamelin R., Potin L., Demurtas D. et al., 2019/05/06. The Journal of experimental medicine, 216 (5) pp. 1091-1107. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_83C31BFEAA5C]

Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment.

Haas Q., Boligan K.F., Jandus C., Schneider C., Simillion C., Stanczak M.A., Haubitz M., Seyed Jafari S.M., Zippelius A., Baerlocher G.M. et al., 2019/05. Cancer immunology research, 7 (5) pp. 707-718. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_AA99A510B25F]

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen M.O., Heath M.D., Cabral-Miranda G., Lipp C., Zeltins A., Sande M., Stein J.V., Riether C., Roesti E., Zha L. et al., 2019/04/26. Journal for immunotherapy of cancer, 7 (1) p. 114. Peer-reviewed.

[URN] [DOI] [Pmid] [serval:BIB_D5AD3DB36450]

Masters thesis

Publications (1)

CANCER IMMUNOTHERAPY WITH VEGFR-3 TARGETED CAR T-CELLS

KIRITSIS K., 2016. 32, Université de Lausanne, Faculté de biologie et médecine, COUKOS G. (dir.).

[URN] [serval:BIB_AD0E970E95CE]

Phd thesis

Publications (3)

Molecular determinants governing CD8+ T cell mediated anti-tumor immunity

Martinez-Usatorre Amaia, 2018/04/27. 117, Université de Lausanne, Faculté de biologie et médecine, Romero Pedro (dir.).

[URN] [serval:BIB_08CEE3B79D75]

Harnessing iNKT and CD8 T cells for Immunotherapy of Cancer

Tschumi Benjamin Olivier, 2018/03/13. 117, Université de Lausanne, Faculté de biologie et médecine, Romero Pedro (dir.).

[URN] [serval:BIB_786BC3B46C6D]

Characterization of local and systemic immune-modulation in melanoma patients

Bordy N., 2015. 204, Université de Lausanne, Faculté de biologie et médecine, Speiser D., Swartz M. (dir.).

[URN] [serval:BIB_9F9512EEBA1F]